Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients

ConclusionPoor PS, short period of time since the previous treatment, and more than one metastatic location were associated with poorer prognostic.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research